BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33678115)

  • 21. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
    Liu HJ; Li GL; Lei PC
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of MgS nanoparticles-Cisplatin-bio-conjugate on SH-SY5Y neuroblastoma cell line.
    Nalci OB; Nadaroglu H; Genc S; Hacimuftuoglu A; Alayli A
    Mol Biol Rep; 2020 Dec; 47(12):9715-9723. PubMed ID: 33191478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosteric and Orthosteric Activators of mGluR8 Differentially Affect the Chemotherapeutic-Induced Human Neuroblastoma SH-SY5Y Cell Damage: The Impact of Cell Differentiation State.
    Jantas D; Grygier B; Zatorska J; Lasoń W
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):443-451. PubMed ID: 29753314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylated chrysin reduced cell proliferation, but antagonized cytotoxicity of other anticancer drugs in acute lymphoblastic leukemia.
    Goto H; Yanagimachi M; Goto S; Takeuchi M; Kato H; Yokosuka T; Kajiwara R; Yokota S
    Anticancer Drugs; 2012 Apr; 23(4):417-25. PubMed ID: 22205153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Omegaven®, EPA, DHA and oxaliplatin on oesophageal adenocarcinoma cell lines growth, cytokine and cell signal biomarkers expression.
    Eltweri AM; Howells LM; Thomas AL; Dennison AR; Bowrey DJ
    Lipids Health Dis; 2018 Jan; 17(1):19. PubMed ID: 29378575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
    Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
    Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemopreventive Effects of Dietary Eicosapentaenoic Acid Supplementation in Experimental Myeloid Leukemia.
    Finch ER; Kudva AK; Quickel MD; Goodfield LL; Kennett MJ; Whelan J; Paulson RF; Prabhu KS
    Cancer Prev Res (Phila); 2015 Oct; 8(10):989-99. PubMed ID: 26290393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eicosapentaenoic acid modifies cytokine activity and inhibits cell proliferation in an oesophageal cancer cell line.
    Kubota H; Matsumoto H; Higashida M; Murakami H; Nakashima H; Oka Y; Okumura H; Yamamura M; Nakamura M; Hirai T
    Anticancer Res; 2013 Oct; 33(10):4319-24. PubMed ID: 24122998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Salzer WL; Devidas M; Shuster JJ; Wang C; Chauvenet A; Asselin BL; Camitta BM; Kurtzberg J;
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):369-75. PubMed ID: 17551397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of Pyk2 pathway and reactive oxygen species (ROS) to the anti-cancer effects of eicosapentaenoic acid (EPA) in PC3 prostate cancer cells.
    Oono K; Ohtake K; Watanabe C; Shiba S; Sekiya T; Kasono K
    Lipids Health Dis; 2020 Jan; 19(1):15. PubMed ID: 32005121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of eicosapentaenoic acid, gamma-linolenic acid and prostaglandin E1 on three human colon carcinoma cell lines.
    Mengeaud V; Nano JL; Fournel S; Rampal P
    Prostaglandins Leukot Essent Fatty Acids; 1992 Dec; 47(4):313-9. PubMed ID: 1337209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eicosapentaenoic acids enhance chemosensitivity through connexin 43 upregulation in murine melanoma models.
    Yang CJ; Kuo CT; Wu LH; Chen MC; Pangilinan CR; Phacharapiyangkul N; Liu W; Chen YH; Lee CH
    Int J Med Sci; 2019; 16(5):636-643. PubMed ID: 31217730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Giordano C; Plastina P; Barone I; Catalano S; Bonofiglio D
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32224850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
    Schwenn MR; Blattner SR; Lynch E; Weinstein HJ
    J Clin Oncol; 1991 Jan; 9(1):133-8. PubMed ID: 1985162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia.
    Okada S; Hongo T; Yamada S; Watanabe C; Fujii Y; Ohzeki T; Horikoshi Y; Ito T; Yazaki M; Komada Y; Tawa A
    Br J Haematol; 2003 Dec; 123(5):802-9. PubMed ID: 14632770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-3 PUFAs have antiproliferative and apoptotic effects on human colorectal cancer stem-like cells in vitro.
    Yang T; Fang S; Zhang HX; Xu LX; Zhang ZQ; Yuan KT; Xue CL; Yu HL; Zhang S; Li YF; Shi HP; Zhang Y
    J Nutr Biochem; 2013 May; 24(5):744-53. PubMed ID: 22854319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies.
    Prabhu VV; Talekar MK; Lulla AR; Kline CLB; Zhou L; Hall J; Van den Heuvel APJ; Dicker DT; Babar J; Grupp SA; Garnett MJ; McDermott U; Benes CH; Pu JJ; Claxton DF; Khan N; Oster W; Allen JE; El-Deiry WS
    Cell Cycle; 2018; 17(4):468-478. PubMed ID: 29157092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of the combination of eicosapentaenoic acid and retinoic acid on the proliferation and differentiation of HL-60 cells].
    Luo H; Mi M; Zhang Q
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):176-8. PubMed ID: 12133451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory Effect of Eicosapentaenoic Acid on the Migration of the Esophageal Squamous Cell Carcinoma Cell Line TE-1.
    Kubota H; Hirai T; Yamauchi A; Ogo A; Matsumoto H; Ueno T
    Anticancer Res; 2020 Sep; 40(9):5043-5048. PubMed ID: 32878792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.